3^rd Annual Summit on

AIDS

AIDS 2019

Theme: ENHANCING COMPETENCY IN HIV PREVENTION AND CARE

We are delightful to welcome you to the “3rd Annual Summit on AIDS” which is going to be scheduled on September 18-19, 2019 at Singapore. This conference is a global platform for AIDS Disease Professionals where we assure you to have knowledge with scholars from around the world for the best current strategies for diagnosis and treatment of AIDS. Worldwide 300+ conferences are being organized by Meetings International Pte Ltd i.e. USA, Europe and Asia pacific regions. The exciting and innovative program brought together national and international experts to promote the exchange of the latest clinical practices and cutting-edge research in AIDS 2019. World-renowned doctors, researchers, scientists, speakers, the most recent techniques, tactics, and the newest updates in respective field are hallmarks of this AIDS 2019 Conference. The field of AIDS Disease is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. The importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.

Session 1: HIV/AIDS and Retroviral Diseases

36.9 million People in world were living with AIDS in 2017; it was 33.2 million in 2010, the result of continuing new infections, people living longer with HIV, and general population growth. Global prevalence has leveled since 2001 and was 0.8% in 2016. Despite these challenges, new global efforts have been mounted to address the epidemic and there has been significant progress. This AIDS 2019 conference will also include the topic of retroviruses diseases. Retroviruses induce diseases that do not fit easily into any of the major categories and different tissues can influence the type of disease that develops the first retrovirus associated with disease was equine infectious anemia virus (EIAV). BFU-E and CFU-E contained by anemic cats is very less and FeLV infection suppresses the generation of these precursors in vitro. While murine retroviruses are inactivated by human complement and are not capable of causing human disease.

Related Conference: 21^stInternational Conference on HIV and AIDS, May 23-24, 2019, London, UK; 26^thConference on Retroviruses and Opportunistic Infections, March 4-7, 2019, Seattle, USA; 25^thAnnual BHIVA Conference, April 2-5, 2019, Bournemouth, UK; 10^thIAS Conference on HIV Science, July 21-24, 2019, Mexico, USA; 17^thEuropean AIDS Conference, November 6-9, 2019, Basel, Switzerland; National HIV Prevention Conference, March 18-21, 2019, Atlanta, USA; STI & HIV 2019 World congress, July 14-17, 2019, Vancouver, Canada; 9^thInternational Workshop on HIV Persistence during Therapy, December 10-13, 2019, Miami, USA.

Session 2: HIV Related Infections, Co-infections and Cancers

There are a number of people living with HIV, infections and cancers. In AIDS 2019 Conference we will endeavor to talk about continuous research of this theme. HIV, co-infections and cancers are Hepatitis B, hepatitis C, tuberculosis, sexually transmitted infections (STIs), human papillomavirus (HPV) and herpes, and fungal infections, Hodgkin’s lymphoma, lung cancer, skin cancer, anal cancer, cervical and vaginal cancer in women, and testicular and prostate cancer in men. These growths can frequently be effectively treated on the off chance that they happen in individuals with HIV who keep up solid safe frameworks with HIV treatment.

Session 3: Stigma, Discrimination and Lived experience with HIV

People living with HIV and AIDS have to face negative attitudes and abuse, these kind of activity refers to HIV-related stigma and discrimination. Stigma and discrimination continue to undermine prevention, treatment and care of people living with the HIV and AIDS. It hinders those with the virus from telling their partners about their status. It threatens their access to health care. It increases their vulnerability to physical violence. And HIV-related stigma affects people’s ability to earn a living, making it even more difficult for them to lift themselves out of poverty. These all limit access to HIV testing, treatment and other HIV services. Knowing that you are HIV-positive can be one of the worst experiences you go through in life. But, HIV will not restrict you from living a long, happy and healthy life. With the right treatment and support, it is possible to live as long as the average person. In our society, there are a lot of misconceptions about what it means to be living with HIV. Ultimately, how you cope with your diagnosis and how you move forward will matter as everyone’s lives are different. STD-AIDS Conference will gather community and society which are fighting against discrimination.

Session 4: HIV relation with Cardiovascular diseases and Aging

Human immunodeficiency virus-infected individuals are at increased risk for CVD.Timely initiation of ART with consequent viral suppression is likely to reduce CVD events and to offset probable side effects from ART-induced metabolic changes. Reduction in smoking in HIV-infected individuals is a public health priority. Cardiovascular disease (CVD) includes a group of problems related to the heart (cardio) or to blood vessels (vascular.) CVD coronary heart disease (heart attacks), angina (chest pain from lack of blood to the heart), cerebrovascular disease (problems with blood vessels in the brain, including stroke), peripheral artery disease (blocked blood vessels in the legs), rheumatic heart disease (a complication of a throat infection), congenital heart disease (due to a birth defect) and heart failure.

Session 5: HIV Diagnosis and Therapy

HIV contamination represents a range of sickness that can start with a short intense retroviral disorder that normally advances to a multiyear chronic and clinically latent ailment. Without treatment, this sickness inevitably advances to a symptomatic, life-threatening immunodeficiency illness known as AIDS. HIV replication is available amid all phases of the contamination and progressively depletes CD4 lymphocytes, which are critical for maintenance of effective immune function. Your doctor can diagnose HIV by testing blood for the presence of antibodies to HIV. After infection, HIV antibodies may take as long as six months to be produced in quantities large enough to show up in standard blood tests.

Session 6: HIV Drug Discovery, Research & Vaccines

After the virus was discovered 25 years ago the development of drugs for HIV infection began. Since then, progress has been substantial, but numerous uncertainties persist about the best way to manage this disease. Here we review the current treatment options, consider novel mechanisms that can be exploited for existing drug targets, and explore the potential of novel targets. With a view to the next quarter century, we consider whether drug resistance can be avoided, which drug classes will be favored over others, which strategies are most likely to succeed and the potential impact of pharmacogenomics and individualized therapy.

Vaccines have been our best weapon against the world’s deadliest infectious diseases, including smallpox, polio, measles, and yellow fever. An effective preventive AIDS vaccine would teach the body how to prevent HIV infection. Vaccines are the most powerful public health tools available and an AIDS vaccine would play a powerful role in ensuring the end to the AIDS epidemic. An HIV vaccines does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years.

Session 7: Viral, Bacterial, Fungal & Protozoan STDs

STDs can be spread with sexual activity, depending on the disease. STDs are most often by viruses and bacteria. The following is a list of the most common STDs, their causes. Additionally, there are other infections (see STDs with asterisk mark) that may be transmitted on occasion by sexual activity, but these are typically not considered to be STDs by many investigators. Bacterial STDs are caused by bacteria and Viral STDs are caused by viruses, this is the main difference between these two categories of (STDs). As a result of being caused by different microorganisms, bacterial and viral STDs vary in their treatment. Bacterial STDs, such as gonorrhea, syphilis, and chlamydia, are often cured with antibiotics. But viral STDs, (the four “H’s”) such as HPV, HIV, herpes, and hepatitis (the only STD that can be prevented with a vaccine), have no cure, but their symptoms can be alleviated with treatment.

Session 8: Advocacy & Community Engagement in HIV Research

Community engagement, joining components of the more extensive ideas of public and partner engagement, is progressively advanced all around, including for health research led in developing nations. In sub-Saharan Africa, people group engagement needs and difficulties are ostensibly heightened for studies including gay, bisexual and other men who have intercourse with men, where male same-sex sexual interactions are frequently exceedingly trashed and even unlawful.

Session 9: Immunology and Infertility of STDs/STIs

Adults with immune deficiencies are significantly more inclined to encounter the ill impacts of molluscum contagiosum. Around 90% of patients who are HIV-positive have skin bruises or some resemblance thereof, including molluscum contagiosum. In one review, 18% of patients who were HIV positive were found to have molluscum contagiosum. In immune-deficient people, molluscum contagiosum can spread to all body surfaces. Immunocompetent adults don't get molluscum contagiosum wounds far from the genital zone. The nearness of molluscum contagiosum on the substance of an adult is a better than average marker that they have an HIV ailment or some other immunosuppressive condition. Immunogenetics helps in perception the pathogenesis of a couple of insusceptible frameworks and overwhelming infections and bacterial maladies under clinical examinations of STDs.

Some sexually transmitted contaminations can extent from mother to infant amid labor or breastfeeding, using unsterilized IV tranquilizer needles and blood transfusions. Sexually transmitted contaminations have been around for a large number of years. Microorganisms that exists on the skin or mucous layers of the male or female genital zone can be transmitted, as can living beings in semen, vaginal emissions or blood amid sex.

Sexually transmitted diseases (STDs) are contaminations that are distributed starting with one individual then onto the next through sexual contact. The reasons for STDs are microscopic organisms like bacteria, parasites, yeast, and viruses. There are more than 20 types of STDs, including Chlamydia, Genital herpes, Gonorrhea, HIV/AIDS, HPV, Syphilis, Trichomoniasis. Most STDs influence both men and women, but mostly they cause severe health issues for women. If a pregnant lady has an STD, it can bring about genuine medical issues for the child.

Session 10: Recent Advancement in HIV/AIDS, STDs and STIs

The search for a preventive immunization that can stop the worldwide pandemic is a definitive objective of HIV research. Improvement of an immunization against HIV-1 has been tormented by numerous outlandish difficulties. Distinctive immunization ideas have been tried to conquer these difficulties. Trial immunizations that specified guarantee in preclinical trials were progressed into clinical trials. However, human trials turned out to be an enormous dissatisfaction until the aftereffects of the RV144 trial in Thailand

Urine tests can be used to test for urethritis in both sexual orientations. Late urination will have washed gonorrheal discharge from the urethra. In this way, to accumulate sufficient discharge, pee tests should be taken no not as much as an hour after the patient's last pee. Vaginal swab illustrations are used to test for cervicitis. Gonorrheal cervicitis produces a satisfactory discharge that swabs require not be taken by speculum examination. Or maybe, they can be assembled unpredictably by the patient herself.

Session 11: Current Focus in Virology Research

Branch of science deals with the study of viruses - submicroscopic, parasitic particles of genetic material contained in a protein coat and virus-like agents is called virology. Virology is often considered a part of microbiology or of pathology. Some of our greatest challenges and triumphs have involved virology. Our HIV 2018 conference is bringing experts from the field of HIV, STD AIDS, STIs Vaccines, virology and Immunology or discussion of the latest advances and ideas and to stimulate interdisciplinary interactions. Conference like ours will help to speed up of the development of effective therapies for viral disorders. Traditionally restricting the spread of infectious disease has been able through use of vaccines, antibiotics, antiviral drugs, and public health measures. But in the face of challenges like drug-resistant microbes and the emergence of HIV, future answers hinge on progressive research in molecular virology and microbiology.

Global Market Analysis for AIDS:

There are around 36.7 million people suffering from HIV infection in 2015 (WHO studies). The burden of HIV/AIDS increases with time, varies according to region and the countries, where Sub Saharan Africa leads with 1 in 25 people living with HIV. There is global efforts been put to create awareness, build health community and society to prevent HIV and aid in treatment of HIV affected people. The global HIV/AIDS diagnostics market is expected to further grow during the forecast period due to factors such as rising in incidence of HIV infections, awareness about available diagnostic and treatment options and technological advancement in diagnostic tests. HIV diagnostic tests have evolved over the period of time by reducing the window period for result delivery. Use of rapid test for HIV diagnosis has increased their coverage to peripheral areas with minimum specialised facility. Enhanced accuracy of the tests and simple usage has further attracted people to get tested and easy access to the healthcare. In developing countries such as China, India and others, with growing population, rising awareness, government initiatives in prevention and management of HIV-AIDS, the market will witness further growth.

The HIV/AIDS diagnostics market mainly consists of antibody test, HIV-2 & Group O diagnostic tests, viral load tests, CD4 testing, early infant diagnostics, viral identification testing. Antibody test will continue to occupy dominant position through the forecast period. As of the current market scenario, North America followed by Europe dominate the global HIV/AIDS diagnostics market due to increasing incidence of HIV infected population, technological advancement in diagnostic and treatment for AIDS, awareness programs and government aided healthcare initiatives and access. Asia Pacific is the fastest growing regional market driven by factors such as rapidly increasing HIV population, rising awareness about HIV and blood transfusion risks, improvement in healthcare infrastructure in emerging economies.

HIV in Europe:

At the end of 2015, the cumulative number of people diagnosed with HIV in the WHO European Region increased to over 2 million. More than 153 000 new HIV cases contributed to this figure in 2015 – a 7% increase compared to the previous year and the highest annual number since reporting began in the 1980s. Alarmingly, around a third of those people do not know that they are infected. Despite the progress in achieving universal access to HIV prevention, treatment, care and support across the Region over the last decade, the response to the HIV epidemic still faces many challenges. The WHO European Region is the only region worldwide where the number of new HIV infections is rising. One reason for this worrying trend: over half (51%) of the reported HIV diagnoses happen in a late stage of infection.

HIV in USA:

Around 1.1 million people are living with HIV in the United States of America (USA). Nearly one in seven of these people are unaware they have HIV. The size of the epidemic is relatively small compared to the country’s population, but is heavily concentrated among several key affected populations. The USA is the greatest funder of the global response to HIV, but also has an ongoing HIV epidemic itself, with around 37,600 new infections a year. Stigma and discrimination continue to hamper people's access to HIV prevention as well as testing and treatment services, which fuels a cycle of new infections. HIV rates are higher in southern states, which are home to around 45% of all people living with HIV, and account for around half of the new diagnoses annually in the USA, despite making up roughly one-third (37%) of the population. Since the beginning of the HIV epidemic, 692,790 people have died of AIDS-related illnesses in the USA

HIV in Asia:

The Asia and Pacific region was home to an estimated 5.2 million people living with HIV/AIDS in 2017. China, India and Indonesia account for almost three-quarters of the total number of people living with HIV in the region. It is increasingly clear that the Asia and Pacific region is falling behind Africa in its HIV response. In 2017, 74% of people living with HIV in this region were aware of their status. Among those diagnosed with HIV, 71% were on treatment and 85% were virally suppressed. In terms of treatment coverage this equates to 57% of all people living with HIV being on treatment and of those, just 45% being virally suppressed. In 2017, 280,000 people became infected with HIV in the region. Although new infections declined by 14% between 2010 and 2017, progress has slowed in recent years and new infections are on the rise in some countries. In particular, Philippines and Pakistan are facing rapidly expanding HIV epidemics.

HIV in Middle East:

The Middle East and North Africa (MENA) region has the lowest HIV prevalence in the world (0.1%) with 230,000 people recorded to be living with HIV/AIDS in 2016. This is in contrast to sub-Saharan Africa, which has the highest HIV prevalence of all regions (7.1%).Moreover, in 2016, there were roughly 18,000 new HIV infections – only a small 4% decrease on the previous year. Over half (65%) of the new infections recorded during the year occurred in Iran, Sudan and Somalia. Across the region’s countries in 2016, just 58% of people living with HIV were aware of their status, 41% of people living with HIV and aware of their status were on treatment, and just 66% of those people were on treatment achieving viral suppression.

HIV in Netherlands:

The majority of registered and monitored adults living with HIV/AIDS in the Netherlands are male (80%). Amongst men, homosexual contact was by far the greatest risk factor (72%), whereas heterosexual transmission was the greatest risk factor (88%) amongst women. Despite improved testing in The Netherlands over the last two decades, even today, 43% of infected individuals are diagnosed late in the course of their infection. As such, many people in the Netherlands are unaware that they are living with HIV, this has serious implications for both the individual and public health as it can increase the risk that HIV/AIDS will be transmitted.

In 2016, an estimated 23,000 Netherlanders are living with HIV/AIDS, out of the 17 million total populations. Less than 500 estimated new HIV/AIDS infections occurred in 2016. Gender prevalence amongst adults (15-49) shows women at .1% compared to men at .3%. Out of the 23,000 Netherlanders living with HIV, approximately 18,600 are on treatment.

Scope:

The HIV therapeutics market was worth around $14 billion worldwide in 2013, and at a Compound Annual Growth Rate (CAGR) of 0.9%, Global Data ventures this market to achieve a sum of $15 billion in deals by 2023. These deals are required to come prevalently from the US showcase, as money related starkness measures remain an essential hindrance to the development of the HIV advertise in alternate nations canvassed in this report. Over Global Data's 2013–2023 gauge period, the expanded take-up of STRs is required to drive advertise development. KOLs met by Global Data expect that INI-based STRs — drove by ViiV's Triumeq and Gilead's Quad 2 — will rule the commercial center for the length of the figure time frame. Antiretroviral therapy, a breakthrough treatment for HIV infection, suppresses the levels of circulating HIV viral particles in the blood. When it works, it results in radical improvement in health and life expectancy for HIV-positive individuals. HIV resistance to the antiviral tenofovir, one of the mainstays of HIV treatment and prevention, is increasingly common following therapy, particularly in low and middle-income countries, according to a new, multi-national study. With the study of areas related to AIDS/HIV, HIV status, HIV Vaccines, Advances in HIV treatment, Diagnosis and Treatment of AIDS/HIV, Transmission of HIV, Advances in HIV Tests, HIV Vaccines, Innovative HIV drugs. Every year, around 300,000 cervical cancer deaths are registered due to HPV. The same data show approximately 1,370,000 deaths by acquired immune deficiency syndrome (AIDS) worldwide in the countries.

Universities related to HIV/AIDS Worldwide:

USA:

Augusta University

Wayne State University

Penn University

University of Maryland

Drexel University

University Of Miami

University of Georgia

Harvard University

Washington University

University of Illinois

University of Minnesota

University of Charleston

West Virginia University

University of Wisconsin

Europe:

University of Cambridge

University of Oxford

University of Copenhagen

University College London

Swiss Federal Institute of Technology Zurich

Imperial College London

University of Zurich

Karolinska Institute

University of Manchester

University of Munich

University of Edinburgh

Pierre and Marie Curie University

Catholic University of Leuven

Heidelberg University

University of Helsinki

Asia Pacific:

Osaka University

University of Tokyo

National University of Singapore

Kyoto University

Mahidol University

Tel Aviv University

University of Hong Kong

Keio University

Hebrew University of Jerusalem

Seoul National University

National Taiwan University

Sun Yat-sen University

Fudan University

Zhejiang University

Peking University

Middle East:

Alexandria University

Cairo University

American University of Kuwait

The Lebanese American University (LAU)

Weill Cornell Medical College in Qatar

Paris-Sorbonne University Abu Dhabi

Mohammed bin Rashid University of Medicine and Health Sciences

Hebrew University

King Saud bin Abdulaziz University for Health Sciences

King Saud University

Gulf Medical University

Sana'a University

HIV Related Association & Societies:

USA:

American Academy of HIV Medicine

American Sexual Health Association

Association of Nurses in AIDS Care

Association for Professionals in Infection Control and Epidemiology

International AIDS Society - USA

International AIDS Society

Infectious Diseases Society of America

British HIV Association

Australasian Society for HIV Medicine

HIV Medicine Association

International Association of Physicians in AIDS Care

National Medical Association

HIV Medicine Association

Europe:

The European AIDS Clinical Society

Aids Hilfe Wien Austria

EATG (European AIDS Treatment Group) Belgium

Czech AIDS Help Society Czech Republic

AIDS Fondnet Denmark

Deutche AIDS-Hilfe / AIDS Action Europe Germany

Global Network of People Living with HIV Netherlands

ARAS - Romanian Association against AIDS Romania

Alliance Global Ukraine

European AIDS Treatment Group

HIV Pharmacy Association

Asia Pacific:

CARAM Asia

National AIDS Programme

National Center for HIV/AIDS, Dermatology and STDs

AIDS Concern

Hong Kong AIDS Foundation

The Society for AIDS Care

HIV Medicine Association of India

AIDS Clinical Center

Korean HIV/AIDS Prevention and Support Center

Taiwan Tongzhi Hotline Association

Middle East:

Egyptian AIDS Society

Egyptian Network of NGOs fighting AIDS

AIDS Research Center of Iran

HATAM - HIV/AIDS Treatment and Research Center

Pozitif Yasam Dernegi (Positive Living Association)

Saudi Charity Association for AIDS Patients

National AIDS Programme

Israel AIDS task force

National HIV/AIDS program

Funding bodies:

Centers for Disease Control (CDC)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Child Health and Human Development (NICHD)

NIH Office of AIDS Research (OAR)

Irish Aid

Elton john AIDS foundation

Mac AIDS fund

The global fund

Conclusion: Unprotected sex with an HIV-positive individual does not inevitably lead to HIV/AIDS transmission. HIV/AIDS exposure is also extremely unlikely when there is not enough infectious virus in sexual fluids due to successful antiretroviral treatment. Neither are spitting, biting and throwing body fluids significant risks of HIV/AIDS exposure. AIDS 2019 Conference provided a much needed platform for exchanging and strengthening knowledge and resources regarding HIV/AIDS testing and care in Europe and neighbouring countries. As the discussions and wealth of evidence presented show, many researchers, policy-makers, service providers and advocates are working to better understand and indentify evidence-based solutions to this crucial health challenge.

References:

https://www.amfar.org
https://www.researchandmarkets.com/research/cn7rz6/global_hiv?w=4
http://www.acutemarketreports.com/report/hiv-aids-diagnostics-market
https://www.kaloramainformation.com/HIV-Diagnostics-Therapeutics-1646600/

Highlights
Supporting Journals

HIV/AIDS and Retroviral Diseases
HIV Related Infections, Co-infections & Cancers
Stigma, Discrimination and Lived Experience With HIV
HIV relation with Cardiovascular diseases and Aging
HIV Diagnosis and Therapy
HIV Drug Discovery, Research & Vaccines
Viral, Bacterial, Fungal & Protozoan STDs
Advocacy & Community Engagement in HIV Research
Immunology and Infertility of STDs/STIs
Recent Advancement in HIV/AIDS, STDs and STIs
Current Focus in Virology Research

5 Organizing Committee Members

More...

Media Partners & Collaborations

Media Partner

fgsg
tgh

Dear Eliza, Thank you for that wonderful opportunity given to share my experiences during the conference. I would like to place on record the smooth conduct of the conference. My appreciation goes a long way to Eliza for her timely communication and well advanced information disseminated processes. The presentation schedule and the time mentioned in the mail sent were also strictly followed. All the best. Regards Kalyani Kenneth Speaker | Psychiatry-2021
Kalyani Kenneth

Dear Laura, Thank you for giving me the opportunity to present my current work! I really enjoyed listening and connecting to a wider international scientist through this conference. And I am really looking forward for the physical conference next year! Best regards Sharmaine
Sharmaine Reintar

Many thanks Laura. It iş my plesure work with you
Pinar Kara

It was my pleasure to be a part of the conference. The talks were technically profound. Thank you once again.
Anupam Mukherjee

Thank you very much for the message. I am glad that the presented poster was appreciated. I'm also grateful for the certificate. Dispite my main work was the subject presented in the session, it would be a pleasure to participate in the webinars.
Ana Rita Domingues

Thank you for your appreciation. I love the support received from you and your admirable patience from invitation till the end of the conference. Thank you very much. I hope to participate in future conferences.
Munezza Khan

Am really grateful for you inviting me to this great event... Am thrilled to be part of this great team, I feel honored 😀😃😄🤝🏻
Aysha Haruna

The conference was arranged nicely through a Webex. I found the sessions interactive and informative. I am looking forward to join the next annual meeting of plant genomics in osaka, japan in april 2022.
Ruchika

Highly appreciate your quick response and I am grateful for all your help.
Dr. P T Sunderam

Informative and Innovative sessions
Michael Lacroix

Delightful event with a wonderful sessions
Mohamed Ebraheem Elmesserey

Very much grateful for this opportunity to share the innovative ideas
Mahmoud Metwaly Taha

It was really informative and excellent platform to share the research ideas
Raktima Chakrabarti

Wonderful experience
KHALED NASR ELDIN REYAD

Thank you very much for organizing this wonderful conference
JIMMY KAYASTHA

it was impressive and left me a very good memory.
VAISHALI SAMIR JOSHI

I learnt a lot from the conference and hope to attend the next conference
Deepak Mane

It was a nice and well-organized meeting! Thank you for all your efforts of having put it together.
Vladimir Startsev

The conference was exciting. I enjoyed so much meeting new colleagues at the venue. I would like to express my sincere gratitude to you for your assistance and opportunity. It was a good experience attending this conference.
Daniela Capdepon

It was great being a part of Surgery 2021
Hadi Nural

How much I appreciate your support, you and your job are meaningful. I always wish the best for you. Thank Laura a lot
Kevin Ton

Hats off to you and fellow organizers. Great opportunities for sharing and networking!
Karen Swanepoel

It was a pleasure to participate in this year’s meeting (even in webinar format due to the COVID-19 pandemic) and I hope the participants enjoyed my talk. There were some interesting talks taking place today and the whole experience was enjoyable like last year. Please rest assured that I will be happy to join next year’s meeting as well, hopefully with a physical presence.
Vasileios Fotopoulos

It was my pleasure to attend this conference. Thanks for your kind efforts.
Saeed Taheri

Thank you for your effort for having made "Pharmacology 2019 conference" wonderful success. Thank you again for that.
Ryong Nam Kim

Thanks for holding a nice conference.
Ramin Ataee

I enjoyed the conference. Italy will be a great place to have the next conference. I look forward to 2020 edition.
Paul Njiruh Nthakanio

I am very happy to make a seminar in the conference. If I have a chance to present my work in your conference, I would talk it in your conference in future.
Takayuki Momma

It was good to connect with a diverse group of scientists - thanks very much for the invite
Thomas P Brutnell

It was a nice experience for me to attend plant genomics conference in Osaka and meet researchers from different countries.
Behnam Derakhshani

It has been an excellent experience.Thank you a lot for this opportunity. I enjoyed it very much!
Julio Cesar Vega

I definitely would like to join your conference again. It was so great about everything. I think I would say great coordination and services.
Maryam Jenabi

Great experience being a part of this conference as a moderator
Soizic de Beaucorps

Amazing experience full of knowledge and meeting new people. Looking forward to being back
Thomas Frederick Hartley

Thanks a lot. It was an excellent event. Really enjoyed.
Umesh Prabhu

It was a pleasure and a great opportunity to be one of the Keynote speakers. I welcome the opportunity to speak at additional conferences in the future. Please keep my contact information for future consideration.
Sharon Nixon-Crenshaw

Thank you for assisting in my participation in a superbly organized Conference. I especially appreciate that you made a special session for me. And once again, sincerely thank you for inviting me to the Conference.
Albert Krashenyuk

Thank you for all your help for the meetings. It was for me a great experience to be in a kind and so scientific group.
Katia lollai

I enjoyed a lot thank you. I thank Meetings International for the quality of the event. All the speakers i had notice of were well prepared and highly motivated Compliments!
Dora Dragoni DÄ±vrak

Thank you for organizing the conference. It was nice to partake in the event.
Marcello Menapace

I enjoyed participating in the congress and thank you for your efforts to make it easy for participants. Please keep me in mind for future meetings.
Debendra Kumar Tripathy

It was a nice meet and we had a wonderful time in Paris Thank you once again for the arrangement. I would be interested in participating future meetings.
Prasanna Udupi Bidkar

Thank you so much for giving me a chance to my research presentation in your conference.
Seyedataollah montazam

I enjoyed being in the conference. Thanks for you excellent arrangement for my participation. Looking forward for next meetings.
Afaf El Ansary

The conference is very nice, Thank you so much for inviting me to your esteemed event.
Esmira Naftali

The conference was very good. I hope to attend similar meeting in future. Thank you .
Lia Monica Junie

I am indeed glad to acknowledge that for last two days during Optics-2018, International conference on Lasers, Optics and Photonics it was Successfully conducted and we had very fruitful discussions and interactions to make many great friends for life. Many Delegates had interactions with many famous Japanese University Professors and company Managers too for their future possibilities of R&D collaborations. I had arranges a session for such interactions while eating and discussing with relaxed environment and taking group pictures. The hospitality provided by your Organization Committee Members was excellent to help completing Conference Inauguration, all Keynote Speeches, Oral Presentations And Poster session had very high-quality research presentations in many advanced research areas such as Spectroscopy, Ultra high power Lasers, Fibers, Advances in stabilized high frequency mode-locked pulsed Fiber Lasers, MEMS, Optical Interconnects, Photonics and Advanced Optical Biomedical Imaging, THz and optical communications and Interconnects, theoretical and experimental research and so on from highly recognized Professors and Researchers in Japan and advanced institutions in many advanced countries.
Dr. Brahm Pal Singh

I wish to thanks you for my perfect time on conferense in Osaka. It was great experience for me.
Anton Podkopaev

I wish to thanks you for my perfect time on conferense in Osaka. It was great experience for me.
Dr. Anton Podkopaev

I would refer this organization future conferences to my colleagues and also love to join again in diabetes related events. More topics on diabetes should be there in future diabetes conferences.
Radia Boufermes

Thank you for the invitation and the opportunity to participate. It was very good.
Juliana Francisca Grossi Heleno

Thank you very much for the invitation and it was a great honor for me to join this conference. I had a great time.
Alkis Konstantinopoulos

It was a good event and got to make good friends out there.
Nur Ozel

Thank you so much. Really we appreciate the Congress, hope next time it will be longer. Everything was ok, the venue, colleagues, organizing team. Thank you and hope to meet soon in other Congress soon.
Sameh Samy Abdou

It was a great pleasure of mine to be there during the conference looking forward to joining your future conferences
Ahmed Halim Ayoub

The theme of the conference and the scientific panel are very interesting! I am looking excited to learn many new things on this innovative platform
Lisa mattheu

I would love to attend the Infectious Diseases 2019 conference. The hospitality, the renowned speakers, and the city are awesome. Looking forward to it!
Dr. Ianane Jireh Ramos canizares

Hello Daniel, Thank you for the invitation to the conference. It was an interesting experience. I am glad that my presentation was liked. Like the effects of my work. Stay in touch. Best Regards !
Aneta Zymon

Thank you to Daniel Raybin with Wound Care 2018 for allowing me to be the Keynote Speaker for the conference. Dr. Jeff Mayo and I met colleagues from other countries such as Poland and Ukraine that work in plastic medicine and surgery. We are excited to share our knowledge of wound care in the veterinary industry so that our human medicine counterparts can offer the same standardized care that we utilize in the US. Thank you to Regenlabs for sponsoring the event and Jorgensen Laboratories for providing us with a great sponsor to represent our mission.
Nicole LaForest

Dear Daniel! Thank you for the conference, for your accommodation and the opportunity to see the most romantic, mysterious, fabulous Amsterdam
Nadiia Nor

Congress was good, the quality of the presentations was good. The choice of Singapore as strategic headquarters has been good
Buonocore D

Thanks for your invitation. I enjoyed participating at he conference in Rome and am interested in participating again next year in Paris.
Daniel Benetti

Great experience!! Thanks a lot for the opportunity to speak.
Jose Carlos Ferreyra Lopez

Dear Julie, Many thanks to you as you offered me this opportunity to come and participate at this valuable event in Chicago. I think you are great professional and made huge efforts for the event in terms of organization, engaging speakers, etc. And also you have sense for people, act as empathic person what is very important for me. I was very happy and honored to be invited as a speaker at World Biosimilars Conference in terms to present company Ewopharma AG as business partner of different pharma companies in Central and Eastern Europe, especially company Biogen with its portfolio of biosimilars and share my commercial experience in launching biosimilars! I found the conference interested in terms you selected very qualitative speakers from different areas: innovation and science, manufacturing and commercialization. From my perspective, the most interesting topics were: Sarfaraz K Niazi: “Biosimilars: Why are they so widely misunderstood?” Ronald P Dudek: “The adapter CAR Platform: From antibody to CAR T cell therapeutic” Jose Carlos Ferreyra Lopez: “Market access barriers and market value in Mexican public sector for biosimilars” Milind Antani: “Similar biologics in India- Impact of regulations on business” Joel I Osorio: “RegenerAge System “ (So I will be very happy if you could share these mentioned presentations with me!). I can see more potential for further improvement to put 100% focus on Biosimilar topics and to attract more specialists/professionals to gather. It will be excellent if you could attract more speakers from Europe to share their experience. So please consider this option how to attract them in the future (if I got some nice ideas will share with you!).
Sandra Simic

Thanks for giving opportunity to share my research at 3d printing conference .I meet global experts and exchange our ideas.Two days conference are going very good ,workshop session,exhibition .I felt moved to contribute next year also..
Rajkumar Velu

It is wonderful conference of 3d printing & Bio printing in health care .participates are coming from world wide 3d printing & Bio printing experts .Workshop sessions is too good .
Lifeng Kang

• Good workshop session at conference with lots of discussion among audiences and speakers about the regulatory aspect of 3D printed medical devices. • Many of the topics were good and interesting. • It will be good if the organizer could have invited more participants as well as selecting the speakers based on proven and relevant track record. • It will be better if there are people who keep track of the time for each topic.
Albert Sutiono

Conference was superb. It was well conducted. I appreciate all the speakers, presenters and organizers. I am very proud to be part of this event.
Rajani singh

We had a very good session at cardiomersion in which we discuss about the integrated cardiomersion approach to the delivery of cardiovascular case. Thank you to all the speakers who came across the globe. Finally I would like to thank the organizers for making such a remarkable event.
Deepak Puri

I have been a part of this conference and I am very proud to see the conference very well organized and people are helping us and each other to present their case reports and research. Thank you very much to the organizers for making such great events
Suresh Vatsyayan

The event was very nice and I want to thank all the participants, presenters and the organizers. We hope in future we will have more events like this
Yuan Chen

The BABE conference was very interesting and lot of scientific sessions were covered and highlighted. Special thanks to the Organizing Members and the participants
Kateryna Zupanets

Conference was good, thanks for organising. I felt moved to contribute throughout, and felt that to a certain extent I acted as a moderator throughout the event .It is very happy for me.
Alexander M. Korsunsky

I want to express my graduate and thanks to you for all efforts you put to organize such a successful conference. For 2 days I enjoyed the company of brilliant and beautiful minds from all over the world. I had a great chance to exchange expercties with them and in large my horizons. I want to thank you again for organizing the International Conference of Petroleum Engineering 2018, Dubai, UAE and hope to meet you again very soon.
Essa Georges Lwisa

I enjoyed participating in the congress and thank you for your efforts to make it easy for participants. Please keep me in mind for future meetings relating to bariatric surgery, I would be interested in participating or being part of the organizing committee.
Peter Harris

Meetings International meetings are great way to receive way to receive other scientists in different parts of the world doing, These meetings provides the opportunity for you to work at latest concepts from different peoples also specifically it allows the opportunity to call to the new relationships when it resolves in future collaboration across the photolamps
Suzanne Tinsley

I enjoyed conference with Meetings International it is a mutal legitimate.It is always with first move which encourages scientists for practicing ability based practice It also gives lots of opportunity for discussions as well as collaborations in future
Dr. Marie Vazquez Morgan

We enjoyed the meeting so much. Wish you all success in the coming meetings.
Richa Jaiswal

It was a great experience for us to attend the conference. Had good interactions with speakers. Many thanks to you and Mr Peter Harris for giving us opportunity to participate and visit Japan as well. Wish to attend further conferences in future!
Kalpana Kulkarni

The first day was very good. It was meaningful to spend academic meeting. I thank you for your consideration.
Gagan Dhall

International meeting was good looking forward for next meetings.There can be more we can do because there is always scope for improve.
Suman Lata

Thanks for your greeting letter! We enjoyed the conference. Sure! We will meet again in 2019!
Dra Milagrosa C. S. Liu

First of all I would like to say many thanks to YOU and The Organization / Planning Committee, for I have been given the opportunity to join in this very Prestigious Event. I am also grateful to meet with researchers from other countries who have innovative research’s. Hopefully it could upgrade to my knowledge and more increases my interest in this field of science. Nice to join in this event I wish i could be join on the Traditional Medicine 2019.
Yunita Sari Pane

It was great experience for me. My talk was very much liked by all receipients at Osaka.
Mohammad Kamil

I am indeed glad to acknowledge that for last two days during Optics-2018, International conference on Lasers, Optics and Photonics it was Successfully conducted and we had very fruitful discussions and interactions to make many great friends for life. Many Delegates had interactions with many famous Japanese University Professors and company Managers too for their future possibilities of R&D collaborations. I had arranges a session for such interactions while eating and discussing with relaxed environment and taking group pictures. The hospitality provided by your Organization Committee Members was excellent to help completing Conference Inauguration, all Keynote Speeches, Oral Presentations And Poster session had very high-quality research presentations in many advanced research areas such as Spectroscopy, Ultra high power Lasers, Fibers, Advances in stabilized high frequency mode-locked pulsed Fiber Lasers, MEMS, Optical Interconnects, Photonics and Advanced Optical Biomedical Imaging, THz and optical communications and Interconnects, theoretical and experimental research and so on from highly recognized Professors and Researchers in Japan and advanced institutions in many advanced countries.
Dr. Brahm Pal Singh

I wish to thanks you for my perfect time on conferense in Osaka. It was great experience for me.
Dr. Anton Podkopaev

Interesting presentation & worthfull spirit of exchange of experience
Ippei Sakamaki

Thanks a lot we hade a great time and grest conference. We enjoyed the conference .
Chi-Ying Huang

I would like to express my gratitude for your engagement in preparation of the Cancer Therapy Summit 2018. It was a valuable experience.
Hong Qin

Conference was good. Thanks for your support and co operation.
GURUSAMY MARIAPPA

My active partecipation to the Toronto meeting is just over and motivated by it and by Joseph Ndisang who I met there, I'd like to ask and verify whether I could further collaborate more actively, with no expenses for it, within yr network with my long term scientific expertise and long background in the field of diabetes and also at the light of my previous experience with you over the last year.
Marco Songini

“ The organisation and coordination of the international conference of nanotechnology and nanoengineering was at an outstanding level, it was a great honour to participate in such phenomenal event “
Ahmed Abushomi

I also really appreciated all the scientific contact I made within all these participants - Think that in the future if you might request some help for that renewal activity, I might be helping your team of course (I have some suggestions for making better sort / type of presentation activities for invited speakers of course according to my experience in the field).
Jean-paul Lellouche

The conference sesions proceeded successfuly in a hot and friendly atmospher. I observed during the conference every delegate and speaker interacted wit each other and made friend. I am sure that the conference has become a scientific platform to exchange knowledge among the scientists from all over the world, and they wil conduct a new collaborations. During the conference, onsite organizers spent a great efford. I believe that the level and quality and reputation will increase year to year. Unexpected and unavoidable circumstances can occur at everywhere and every activation, and they can be solved easily. Hope to meet you and your team in another conference.
Osman Adiguzel

Thank you for your friendly mail. I enjoyed the conference with interesting speakers. I did not know anybody at the beginning but I found good companions during the conference.The hotel was good but it was located somewhat outside of Paris. Nevertheless, we had a good time. Anyway, thank you again for your invitation.
Nikolaus Stolterfoht

Thank you. Yes the conference was really interesting.
Adil Aghzar

Thank you! I also think that the event was very successful and very interesting. The variety of thematic session and possibility to meet experts from different fields of marine biology and aquaculture was the biggest advantage of the conference. However, it might be useful to attract more participants to next conference.
Magdalena Jakubowska

Thank you for your kind welcome and appreciated support during the appreciable meeting. Thank you for your kind offer to continue to cooperate to this interesting initiative and I am available to cooperate again in remote and to eventually attend the conference. Thank you and your colleagues and the scientific valuable people that attended the conference for your kind cooperation.
Gianluca Ragusa

Thank you for allowing me to participate in this event, I liked the organization and the people who participated, I made many friends too. Of course I would like to collaborate with you in organizing the next Aqua 2019 conference.
Alfredo Olivera Galvez

The meeting was a success with many experience professional.
Nyan Taw

A very thorough and well written set of points. It’s great that you took the time to put this together.
Feng Gao

Thank you for offering an unforgettable experience for all of us. We are honored to attend the conference. We are so happy and thanks a lot.
Stef Stienstra

Many thanks for your continuous support throughout the conference. It was the pleasure to participate and shared the findings at such high level meetings.
Pooja Jain

The conference was very enjoyable and I was honoured to be able to present my research at this prestigious event. The conference was particularly good for me as it is always important to keep up with the new developments
Glenda Gray

I had a wonderful time at the conference and learned so much from the presenters. Thank you kindly for putting this event together.
Marc HV Van Regenmortel

I had a great time in the conference, Everythings are OK, thank you .
Hsiao-Hui Chiu

Wonderful!! thank you for all the help you have done
Sharadha Ramesh

Thank you for your arrangement. Our team enjoyed the meeting so much. Wish you all success in the coming meetings!
CHAN Yui Fung

Surely we will maintain our relation in long run. If there is any opportunity for me to start my carrier being fresher and any guidance from you to me. It will be highly appreciated.
Monika kankarwal

I appreciate your polite contact. I enjoyed my first visit to Singapore. It was meaningful to spend academic meeting. I thank you for your consideration.
Kazue Sawami

Thank you for the email ,it was my sincere honor and pleasure to participate , many thanks for the invitation ,well organised conference, great hospitality ,well composed programme,interesting nursing topics, but not very large group size enough group size to be conducive to excellent discussions, I wish you all the success for your further conference
Hana Kadhom

Thank you for successful conference in Singapore. And thank you for giving me opportunity of oral presentation. It was very good experiences to me.
Hyun, Myung sun.

AIDS 2019

Theme: ENHANCING COMPETENCY IN HIV PREVENTION AND CARE

5 Organizing Committee Members

Kenneth Rodriguez Colindres

Rajiv Rana

Reza Nassiri

Hari Om Singh

Marcel Marcano Lozada

Media Partners & Collaborations